Gossamer Bio, Inc. (GOSS) Earnings
Gossamer Bio, Inc.'s most recently reported earnings, recent earnings filings (8-K) and headline annual financials, sourced from SEC EDGAR.
Last reported earnings
Aug 13, 2026
From the latest earnings 8-K
Revenue • FY2025
$48.47M
▼ 57.7%YoY
Diluted EPS • FY2025
$-0.75
▼ 200.0%YoY
Reported earnings dates are based on the latest 8-K (Item 2.02) filings. The next earnings date is an estimate projected from GOSS's historical reporting pattern, not a company-confirmed date.
Headline financials
| Period | Revenue | Net income | Gross profit | Dil. EPS | Free cash flow | Op. margin | Rev. growth |
|---|---|---|---|---|---|---|---|
| FY2025 | $48.47M | -$170.37M | — | $-0.75 | -$171.34M | -352.2% | -57.7% |
| FY2024 | $114.7M | -$56.53M | — | $-0.25 | -$3.47M | -52.2% | — |
| FY2023 | $0 | -$179.82M | — | $-1.18 | -$159.16M | — | — |
| FY2022 | $0 | -$229.38M | — | $-2.71 | -$187.44M | — | — |
Recent earnings filings
| Filed | Form | Accession |
|---|---|---|
| Aug 13, 2026 | 8-K (2.02) | 0001728117-26-000073EDGAR |
| Jul 27, 2026 | 8-K (2.02) | 0001728117-26-000064EDGAR |
| May 18, 2026 | 8-K (2.02) | 0001728117-26-000036EDGAR |
| Mar 17, 2026 | 8-K (2.02) | 0001728117-26-000018EDGAR |
| Nov 5, 2025 | 8-K (2.02) | 0001728117-25-000082EDGAR |
| Aug 5, 2025 | 8-K (2.02) | 0001728117-25-000069EDGAR |
Never miss a GOSS filing.
Get an email when GOSS files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Oct 18, 2026Source: SEC EDGAR.